Page last updated: 2024-10-29

irsogladine and Ischemia

irsogladine has been researched along with Ischemia in 1 studies

irsogladine: RN given refers to parent cpd; MN 1695 refers to maleate salt

Ischemia: A hypoperfusion of the BLOOD through an organ or tissue caused by a PATHOLOGIC CONSTRICTION or obstruction of its BLOOD VESSELS, or an absence of BLOOD CIRCULATION.

Research Excerpts

ExcerptRelevanceReference
" We tested the hypothesis that maintenance of GJIC protects rat gastric mucosa against ischemia-reperfusion (I/R) stress by using irsogladine, an activator of GJIC, and octanol, an inhibitor of GJIC."3.70Role of gap junctions in inhibiting ischemia-reperfusion injury of rat gastric mucosa. ( Itoh, M; Iwata, F; Joh, T; Ueda, F; Yokoyama, Y, 1998)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Iwata, F1
Joh, T1
Ueda, F1
Yokoyama, Y1
Itoh, M1

Other Studies

1 other study available for irsogladine and Ischemia

ArticleYear
Role of gap junctions in inhibiting ischemia-reperfusion injury of rat gastric mucosa.
    The American journal of physiology, 1998, Volume: 275, Issue:5

    Topics: Animals; Anti-Ulcer Agents; Antibodies, Monoclonal; Cell Communication; Chromium Radioisotopes; Conn

1998